Zoloft Does Not Improve Depression, Even in Severe Cases, Study Finds
Despite their finding, the researchers suggest that SSRIs be given to people who do not meet criteria for depression or anxiety.
Does Active Placebo Response Explain Antidepressant Results?
A new study investigated whether participants guessing if they have an antidepressant or placebo affects response rates.
Multiple Researchers Examining the Same Data Find Very Different Results
A new study demonstrates how the choice of statistical techniques when examining data plays a large role in scientific outcomes.
Systematic Review Finds Antidepressant Withdrawal Common and Potentially Long-lasting
Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.
Are Students Benefiting From the Growth Mindset Model?
Results from two meta-analyses reveal shortcomings with the growth mindset theory as applied in schools.
Perfectionism May Lead to Significant Psychological Distress, Study Suggests
A new study suggests needing to appear perfect to others leads to mental health stigma and a higher risk of untreated psychological distress.
It is Time to Abandon the Candidate-Gene Approach to Depression
The candidate-gene approach to depression goes unsupported and is likely based on bad science, new research finds.
Researchers Find Bias in Industry-Funded Continuing Medical Education
Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.
âDo Antidepressants Work?â is the Wrong Question
âThis research points to the inadequacy of asking the simple question: âDo antidepressants work?â Instead, the value or otherwise of antidepressants needs to be understood in the context of the diversity of experience and the particular meaning they hold in peopleâs lives.â
Researchers: Antidepressant Withdrawal, Not âDiscontinuation Syndromeâ
Researchers suggest that the pharmaceutical industry had a vested interest in using the term âdiscontinuationâ in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
How Do Clients Solicit Medication Changes With Psychiatrists?
Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.
Psychosocial Explanations of Psychosis Reduce Stigma, Study Finds
A review of mental health anti-stigma campaigns finds psychosocial models are effective in reducing stigma, while biogenetic models often worsen attitudes.
New Data Show Lack of Efficacy for Antidepressants
An article published this month in the journal BMC Psychiatry suggests that there is a lack of efficacy for SSRIs and that they significantly increase the risk of serious side effects.
Teacher Perspectives on Student ADHD Medication Use
Qualitative study examines patterns in teacher attitudes and knowledge related to medication of students for ADHD-type behaviors.
Researchers Ask, âWhy Do Antidepressants Stop Working?â
An international group of researchers, including several with financial ties to manufacturers of antidepressants, explore possible explanations for why long-term users of antidepressants become chronically depressed.
Growing Evidence for the Link Between ADHD Diagnosis and Age at School Admission
Researchers detect a striking relationship between the month of school enrollment relative to peers and patterns of ADHD diagnoses in a large sample of elementary school students throughout the US.
After the Black-Box: Majority of Children Starting SSRIs Still Receiving Too High of Dose
In 2004, the FDA added a black-box warning to SSRI antidepressants on the increased risk of suicide among children taking these drugs. A new study suggests that this warning has increased the proportion of children who begin an antidepressant on a low dose, but the majority are still receiving higher than recommended doses.
A Conversation about Having Conversations about Psychiatry
In spite of constantly increasing opportunities to tell different stories to the canonical story of bio-psychiatry, it can be risky for academics to voice a different perspective than the mainstream model of mental illness. In this conversation, a communication professor and a psychology professor discuss their challenges and personal experiences with going against the grain, such as what it means to be labeled âanti-psychiatryâ by colleagues and responding to students upset to learn their medications may not be all they thought they were.
Study Finds Deteriorating Mental Health Among Poor White Americans
Researchers find evidence of low socio-economic status White Americansâ rising distress and declining well-being since the mid-1990s.
Speaking, Not Texting, May Prevent Dehumanization in Disagreements
Researchers found participants were less likely to dehumanize those with whom they disagreed when they heard their voices.
Psychiatrists Raise Doubts on Brain Scan Studies
In a review article for this monthâs American Journal of Psychiatry, Daniel Weinberger and Eugenia Radulescu from John Hopkins University push back against the overreliance on MRI scans in recent psychiatric studies. While acknowledging that they both have contributed to this type of research in the past, the authors warn that âfindingsâ from these studies âpose a serious risk of misinforming our colleagues and our patients.â
Industry Funded Trials Favor Drugs Over Psychotherapy
The researchers conclude that industry funding appears to bias studies towards pharmacotherapy over psychotherapy for the treatment of depression.
Journalists Should Report Their Sources’ Conflicts of Interest
From HealthNewsReview.org: While researchers are usually required to disclose their conflicts of interest in medical journals, media outlets do not often require journalists to disclose...
The Genetics of Schizophrenia: A Left Brain Theory about a Right Brain Deficit in...
In recent months, two teams of researchers in the UK and the US published complementary findings about the epigenetic origins of schizophrenia that have scientific communities who indulge in âgenetic conspiracy theoriesâ abuzz. While these results are intriguing, and no doubt involve pathbreaking research methodologies, this line of thought represents a decontextualized understanding both of the symptoms that are typically associated with schizophrenia, and their causes.
Safety Analysis Weighs Harms and Benefits of Antipsychotic Drugs
The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common.